caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1487676938

David Williams

Internal MedicineProvidence, RII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
145
Beneficiaries
—
Total drug cost
$31K
Distinct drugs
6
Brand share
16.6%
Top prescribed drugs
Metoprolol Succinate35 claims
Atorvastatin Calcium33 claims
Apixaban24 claims
Amlodipine Besylate22 claims
Losartan Potassium19 claims
REFERRAL NETWORK

Where David Williams's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Justina Wu
Cardiology · Boston, MA
1420
Quest Diagnostics Massachusetts Llc
Clinical Laboratory · Marlborough, MA
1322
Laila Akhund
Internal Medicine · Foxborough, MA
1233
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BRIGHAM & WOMENS HOSPITAL, INC.139431
BRIGHAM AND WOMEN'S FAULKNER HOSPITAL, INC1526
Jean Connors
Hematology · Boston, MA
1457
Laila Akhund
Internal Medicine · Foxborough, MA
1222
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.